2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing

BL Wilkoff, L Fauchier, MK Stiles, CA Morillo… - EP …, 2016 - academic.oup.com
Implantable cardioverter-defibrillator (ICD) therapy is clearly an effective therapy for selected
patients in definable populations. The benefits and risks of ICD therapy are directly impacted …
被引用次数：472 相关文章
[PDF] ciat.com.ar

[PDF][PDF] 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing

BL Wilkoff, L Fauchier, SM Al-Khatib, J Almendral… - ciat.com.ar
Programming........................................... e57 Duration Criteria for the Detection of Ventricular
Arrhythmia........................... e57 Limitations of Data on the Duration of Tachycardia Required …
[PDF] harvard.edu

[PDF][PDF] 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing☆☆☆

BL Wilkoff, L Fauchier, MK Stiles, CA Morillo… - Journal of …, 2016 - dash.harvard.edu
Implantable cardioverter-defibrillator (ICD) therapy is clearly an effective therapy for selected
patients in definable populations. The benefits and risks of ICD therapy are directly impacted …

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.

BL Wilkoff, L Fauchier, MK Stiles, CA Morillo… - Journal of …, 2016 - europepmc.org
Implantable cardioverter-defibrillator (ICD) therapy is clearly an effective therapy for selected
patients in definable populations. The benefits and risks of ICD therapy are directly impacted …

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing

BL Wilkoff, L Fauchier, MK Stiles, CA Morillo… - Heart …, 2016 - heartrhythmjournal.com
Programming........................................... e57 Duration Criteria for the Detection of Ventricular
Arrhythmia........................... e57 Limitations of Data on the Duration of Tachycardia Required …

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing

BL Wilkoff, L Fauchier, MK Stiles, CA Morillo… - …, 2016 - pure.johnshopkins.edu
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable
cardioverter-defibrillator programming and testing — Johns Hopkins University Skip to main …

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing

B Wilkoff, L Fauchier, M Stiles, C Morillo, S Al-Khatib… - EP-Europace, 2016 - hal.science
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable
cardioverter-defibrillator programming and testing - Archive ouverte HAL Accéder directement …
[PDF] researchgate.net

[PDF][PDF] 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing $

BL Wilkoff, L Fauchier, MK Stiles, SM Al-Khatib… - researchgate.net
Implantable cardioverter-defibrillator (ICD) therapy is clearly an effective therapy for selected
patients in definable populations. The benefits and risks of ICD therapy are directly impacted …

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing

BL Wilkoff, L Fauchier, MK Stiles, CA Morillo… - EUROPACE, 2016 - iris.unimore.it
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable
cardioverter-defibrillator programming and testing IRIS IRIS Home Sfoglia Macrotipologie & …
[PDF] archive.org

[PDF][PDF] 2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing☆☆☆

BL Wilkoff, L Fauchier, MK Stiles, CA Morillo… - Journal of …, 2016 - scholar.archive.org
Implantable cardioverter-defibrillator (ICD) therapy is clearly an effective therapy for selected
patients in definable populations. The benefits and risks of ICD therapy are directly impacted …